Dr. Datsons Labs Corporate Filings & Announcements

Latest corporate announcements and filings from Dr. Datsons Labs on BSE

Search Inside the pdf :

12 Jun 2015

Company Update

Change in Directorate

BSE India

Dr.Datsons Labs Ltd has informed BSE that the following changes in Directorship of the Company have taken place:1. The Change in designation of Mr. Rajendra Kamat, as a Non Executive Director of the Company with effect from May 25, 2015.2. Mr. Dinesh Surana, appointed as a Additional Director of the Company with effect from May 25, 2015....

Dr. Datsons Labs Ltd.

29 May 2015

Company Update

Updates

BSE India

Dr.Datsons Labs Ltd has informed BSE that the Honble Bombay High Court, while allowing certain application filed by the creditors of the Company in winding up petitions, vide its order dated February 18, 2015, appointed the official liquidator attached to the Bombay High Court as the provisional liquidator of Dr. Datsons Labs Limited (the Company) and directed the provisional liquidator to forthwith take charge/possession of the Companys assets,...

Dr. Datsons Labs Ltd.

12 May 2015

Company Update

Resignation of Company Secretary & Compliance Officer

BSE India

Dr.Datsons Labs Ltd has informed BSE that Mr. Yogesh Patel, has resigned from the post of Company Secretary & Compliance Officer of the Company with effect from May 12, 2015.

Dr. Datsons Labs Ltd.

07 May 2015

Company Update

Appointment of Official Liquidator

BSE India

Dr.Datsons Labs Ltd has informed BSE that the Honble Bombay High Court, while allowing certain application filed by the creditors of the Company in winding up petitions, vide its order dated February 18, 2015 (uploaded on website on March 27, 2015), appointed the official liquidator attached to the Bombay High Court as the provisional liquidator of Dr. Datsons Labs Limited (the "Company") and directed the provisional liquidator to forthwith take...

Dr. Datsons Labs Ltd.

30 Apr 2015

Company Update

Shareholding Pattern For March 31, 2015

BSE India

Dr.Datsons Labs Ltd has informed BSE about the Shareholding Pattern as on March 31, 2015.

pdf

Dr. Datsons Labs Ltd.

10 Apr 2015

Company Update

Clarification

BSE India

With reference to the Increase in Price, Dr.Datsons Labs Ltd has Clarified to BSE as under :"The Company is in the process of exploring various strategic moves by formulating policies and by entering into various agreements for the benefit of its shareholders and it is the policy of the Company to inform the stock exchange(s) whenever the Company proposes to implement the policy decisions of the Board of Directors and that such decisions...

Dr. Datsons Labs Ltd.

10 Apr 2015

Company Update

Clarification sought from Dr.Datsons Labs Ltd

BSE India

The Exchange has sought clarification from Dr.Datsons Labs Ltd with reference to increase in price on April 10, 2015.The reply is awaited.

Dr. Datsons Labs Ltd.

03 Apr 2015

Company Update

Appointment of Woman Director

BSE India

Dr.Datsons Labs Ltd has informed BSE that Ms. Anjali Jadhav, has been appointed as a Non Executive Additional Director of the Company, with effect from April 02, 2015.

Dr. Datsons Labs Ltd.

18 Mar 2015, 12:18PM

Company Update

Updates on Contract Manufacturing

BSE India

Dr.Datsons Labs Ltd has informed BSE that Westminster Pharmaceuticals INC Based out of USA has sent the Company a communication showing interest in Dr. Datsons Labs Ltd contract manufacturing Generic Medicines in Private Label for Westminster Pharmaceuticals INC.

Dr. Datsons Labs Ltd.

12 Mar 2015

Company Update

Ochoa Labs to Expand base in Europe through an Exclusive Contract Manufacturing Partnership for Cancer Drugs …

BSE India

Dr.Datsons Labs Ltd has informed BSE regarding a Press Release dated March 12, 2015, titled "Ochoa Labs to Expand base in Europe through an Exclusive Contract Manufacturing Partnership for Cancer Drugs worth 120 Crore with Dr. Datsons Labs Ltd."

pdf

Is Dr. Datsons Labs Ltd. worth buying?

107 Votes:

Buy 71.96%

Sell 16.82%

Hold 11.21%